Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 375 entries
View as:

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04481932 Org: User:
Start: 07/31/20 End: 12/31/26 Due: 12/31/27

Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01528605 Org: User:
Start: 06/30/10 End: 12/31/12 Due: 12/31/13

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03701022 Org: User:
Start: 10/20/18 End: 06/30/21 Due: 06/30/22

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02905916 Org: User:
Start: 06/30/16 End: - Due: -

Investigation of the Pruritogens of Liver-related Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06364969 Org: User:
Start: 04/20/24 End: 08/01/25 Due: 08/01/26

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT03009461 Org: User:
Start: 06/01/17 End: 12/28/20 Due: 12/28/21

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Phase: N/A Priority: Normal
NCT ID: NCT05171166 Org: User:
Start: 12/24/21 End: 12/31/27 Due: 12/31/28

Early Diagnosis of Oral Cancer by Detecting p16 Methylation

Phase: N/A Priority: Normal
NCT ID: NCT01695018 Org: User:
Start: 02/28/09 End: - Due: -

3D Facial Scanning for Evaluating Autologous Fat Grafting in Craniofacial Deformities

Phase: N/A Priority: Normal
NCT ID: NCT06306326 Org: User:
Start: 04/15/24 End: 03/01/29 Due: 03/01/30

NW-301 TCR-T in Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT06956261 Org: User:
Start: 05/10/25 End: 12/31/27 Due: 12/31/28

Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03564834 Org: User:
Start: 08/23/18 End: 07/30/23 Due: 07/30/24

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression

Phase: N/A Priority: Normal
NCT ID: NCT06685861 Org: User:
Start: 11/11/24 End: 08/01/25 Due: 08/01/26

The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04937673 Org: User:
Start: 07/01/21 End: 12/01/22 Due: 12/01/23

Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01848015 Org: User:
Start: 06/30/13 End: 06/30/16 Due: 06/30/17

Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01625702 Org: User:
Start: 06/30/12 End: 12/31/15 Due: 12/31/16

HER2 Positive CTC in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01847794 Org: User:
Start: 06/30/13 End: 06/30/16 Due: 06/30/17

Healthy School mEAls With Less Salt：an Action to Reduce Salt Intake in School Meals for Children in Rural China

Phase: N/A Priority: Normal
NCT ID: NCT06097884 Org: User:
Start: 10/31/23 End: 07/31/24 Due: 07/31/25

Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05417048 Org: User:
Start: 07/14/22 End: 06/15/24 Due: 06/15/25

Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT01250808 Org: User:
Start: - End: - Due: -

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03344367 Org: User:
Start: 11/16/17 End: 03/31/22 Due: 03/31/23

Study of Nimotuzumab to Treat Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00972465 Org: User:
Start: 06/30/09 End: 04/30/10 Due: 04/30/11

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03636308 Org: User:
Start: 07/17/18 End: 08/01/21 Due: 08/01/22

Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04484506 Org: User:
Start: 10/20/11 End: 12/30/25 Due: 12/30/26

Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04239170 Org: User:
Start: 01/31/20 End: 12/31/22 Due: 12/31/23

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT00703430 Org: User:
Start: 03/31/08 End: 06/30/14 Due: 06/30/15